Product information

Ruxience 100 mg
10 ml
rituximab
4178877
0 / 10
Locked

Product properties

174722-31-7
L01FA01
Pfizer Europe MA
Concentrate for solution for infusion, Concentrate for solution for infusion
€176.72
EU/1/20/1431/001
05415062355008
M44
Public
558311-01

Pharmacist Assessment

Commercialization officially ended — no stock

SAM has flagged this product as commercially stopped (reason: Commercial reasons) and no stock is available from wholesalers. Switching to an alternative is necessary.

No available alternative found in the system. Consult the physician for a therapeutic alternative.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Active
- present

Commercial reasons

Alternative available

Composition

4 ingredients

Substance Type Strength CAS
Active ingredient
10 mg/mL
174722-31-7
Excipient
Excipient
Excipient
23 mg

Additional information

View on BCPI

Availability statistics

Commercialization stopped
384 days
3
0
31/03/2026